Alyeska Investment Group
FTH

Alyeska Investment Group’s Faeth Therapeutics FTH Stock Holding History

Alyeska Investment Group’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Buy
+144,404
New +$3.34M 0.01% 533
2021
Q3 		– Sell
-2,000
Closed -$390K – 785
2021
Q2 		$390K Buy
+2,000
New +$494K ﹤0.01% 663

Other funds holding FTH

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Alyeska Investment Group's FTH Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in Faeth Therapeutics (FTH) in Q2 2026: 144,404 shares worth $3.61M. The stake represents 0.01% of the portfolio and ranks #533 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in FTH as recently as Q2 2021.

Alyeska Investment Group first reported a position in FTH in Q2 2021 and has held it in 2 quarters since. 45 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

  • Alyeska Investment Group held 144,404 shares of Faeth Therapeutics worth $3.61M as of Q2 2026.
  • Faeth Therapeutics was a new Alyeska Investment Group position in Q2 2026.
  • Faeth Therapeutics made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #533 holding.
  • Alyeska Investment Group first reported a position in Faeth Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • 45 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.